{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:42:34Z","timestamp":1775184154420,"version":"3.50.1"},"reference-count":138,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Currently, more and more people are suffering from chronic kidney disease (CKD). It is estimated that CKD affects over 10% of the population worldwide. This is a significant issue, as the kidneys largely contribute to maintaining homeostasis by, among other things, regulating blood pressure, the pH of blood, and the water\u2013electrolyte balance and by eliminating unnecessary metabolic waste products from blood. What is more, this disease does not show any specific symptoms at the beginning. The development of CKD is predisposed by certain conditions, such as diabetes mellitus or hypertension. However, these disorders are not the only factors promoting the onset and progression of CKD. The primary purpose of this review is to examine renin\u2013angiotensin\u2013aldosterone system (RAAS) activity, transforming growth factor-\u03b21 (TGF-\u03b21), vascular calcification (VC), uremic toxins, and hypertension in the context of their impact on the occurrence and the course of CKD. We firmly believe that a deeper comprehension of the cellular and molecular mechanisms underlying CKD can lead to an enhanced understanding of the disease. In the future, this may result in the development of medications targeting specific mechanisms involved in the decline of kidney function. Our paper unveils the selected processes responsible for the deterioration of renal filtration abilities.<\/jats:p>","DOI":"10.3390\/cells13090751","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T09:26:02Z","timestamp":1714123562000},"page":"751","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Unveiling Selected Influences on Chronic Kidney Disease Development and Progression"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7469-7056","authenticated-orcid":false,"given":"Piotr","family":"Fularski","sequence":"first","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5502-0335","authenticated-orcid":false,"given":"Witold","family":"Czarnik","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Frankenstein","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"G\u0105sior","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6799-4746","authenticated-orcid":false,"given":"Ewelina","family":"M\u0142ynarska","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Rysz","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Family Medicine, University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Franczyk","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","article-title":"How Many Cell Types Are in the Kidney and What Do They Do?","volume":"84","author":"Balzer","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151336","DOI":"10.1016\/j.semnephrol.2023.151336","article-title":"Chronic Kidney Disease Burden in Low-Resource Settings: Regional Perspectives","volume":"42","author":"Ulasi","year":"2022","journal-title":"Semin. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Jafar","year":"2021","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic Kidney Disease Diagnosis and Management: A Review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"s03","DOI":"10.1590\/1806-9282.66.s1.3","article-title":"Chronic Kidney Disease","volume":"66","author":"Ammirati","year":"2020","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Anger, E.E., Yu, F., and Li, J. (2020). Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031157"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2019010007","article-title":"GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials","volume":"30","author":"Inker","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.2215\/CJN.02660221","article-title":"Classification of Uremic Toxins and Their Role in Kidney Failure","volume":"16","author":"Rosner","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lim, Y.J., Sidor, N.A., Tonial, N.C., Che, A., and Urquhart, B.L. (2021). Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Toxins, 13.","DOI":"10.3390\/toxins13020142"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4070\/kcj.2021.0995","article-title":"Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication","volume":"51","author":"Kim","year":"2021","journal-title":"Korean Circ. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.34067\/KID.0000912022","article-title":"Dual RAAS Blockade in CKD: Does the Hype have Teeth?","volume":"3","author":"Rifkin","year":"2022","journal-title":"Kidney360"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hsu, C.-N., and Tain, Y.-L. (2021). Targeting the Renin\u2013Angiotensin\u2013Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052298"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/HYPERTENSIONAHA.119.12941","article-title":"Maternal High-Fructose Intake Induces Multigenerational Activation of the Renin-Angiotensin-Aldosterone System","volume":"74","author":"Seong","year":"2019","journal-title":"Hypertension"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"108975","DOI":"10.1016\/j.cbi.2020.108975","article-title":"Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease","volume":"317","author":"Gupta","year":"2020","journal-title":"Chem. Interact."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1152\/physiol.00024.2007","article-title":"Renin Release","volume":"22","author":"Schweda","year":"2007","journal-title":"Physiology"},{"key":"ref_18","first-page":"183","article-title":"Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review","volume":"4","author":"Wu","year":"2011","journal-title":"Am. Chin. J. Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3239057","DOI":"10.1155\/2022\/3239057","article-title":"Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome","volume":"2022","author":"Ma","year":"2022","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"107680","DOI":"10.1016\/j.exer.2019.05.020","article-title":"The renin-angiotensin-aldosterone system and its therapeutic targets","volume":"186","author":"Danser","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ar\u0131c\u0131, M. (2023). Management of Chronic Kidney Disease, Springer.","DOI":"10.1007\/978-3-031-42045-0"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nehme, A., Zouein, F.A., Zayeri, Z.D., and Zibara, K. (2019). An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology. J. Cardiovasc. Dev. Dis., 6.","DOI":"10.3390\/jcdd6020014"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/07853890.2020.1758341","article-title":"Local ocular renin\u2013angiotensin\u2013aldosterone system: Any connection with intraocular pressure? A comprehensive review","volume":"52","author":"Holappa","year":"2020","journal-title":"Ann. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/pr.113.008136","article-title":"MAS and its related G protein-coupled receptors, Mrgprs","volume":"66","author":"Bader","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.pharep.2015.03.017","article-title":"Perspectives for angiotensin profiling with liquid chromatography\/mass spectrometry to evaluate ACE\/ACE2 balance in endothelial dysfunction and vascular pathologies","volume":"67","author":"Olkowicz","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e13505","DOI":"10.14814\/phy2.13505","article-title":"Cardiovascular effects of small peptides of the renin angiotensin system","volume":"5","author":"Moraes","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","article-title":"Targeting the renin-angiotensin-aldosterone system in fibrosis","volume":"91\u201392","author":"AlQudah","year":"2020","journal-title":"Matrix Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2010.30","article-title":"Aldosterone: Effects on the kidney and cardiovascular system","volume":"6","author":"Briet","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s40620-020-00803-3","article-title":"Blood pressure reduction and RAAS inhibition in diabetic kidney disease: Therapeutic potentials and limitations","volume":"33","author":"Leoncini","year":"2020","journal-title":"J. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J. Veter. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-981-13-8871-2_16","article-title":"TGF-\u03b2\/Smad and Renal Fibrosis","volume":"1165","author":"Ma","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gifford, C.C., Pandey, R., Raj, V.S., Sabbisetti, V.S., and Ajay, A.K. (2023). Autophagy as a Therapeutic Target for Chronic Kidney Disease and the Roles of TGF-\u03b21 in Autophagy and Kidney Fibrosis. Cells, 12.","DOI":"10.3390\/cells12030412"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.3389\/fphys.2018.01755","article-title":"The Use of Targeted Next Generation Sequencing to Explore Candidate Regulators of TGF-\u03b21\u2019s Impact on Kidney Cells","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jcmm.14028","article-title":"Protease-activated receptor-1 contributes to renal injury and interstitial fibrosis during chronic obstructive nephropathy","volume":"23","author":"Waasdorp","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2014020192","article-title":"EGF receptor deletion in podocytes attenuates diabetic nephropathy","volume":"26","author":"Chen","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1681\/ASN.2011070645","article-title":"EGFR signaling promotes TGF\u03b2-dependent renal fibrosis","volume":"23","author":"Chen","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ki.2012.435","article-title":"Role of epidermal growth factor receptor in acute and chronic kidney injury","volume":"83","author":"Tang","year":"2013","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Panizo, S., Mart\u00ednez-Arias, L., Alonso-Montes, C., Cannata, P., Mart\u00edn-Carro, B., Fern\u00e1ndez-Mart\u00edn, J.L., Naves-D\u00edaz, M., Carrillo-L\u00f3pez, N., and Cannata-And\u00eda, J.B. (2021). Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010408"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1042\/CS20180563","article-title":"Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy","volume":"132","author":"Bao","year":"2018","journal-title":"Clin. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pharmthera.2018.10.013","article-title":"P53 in kidney injury and repair: Mechanism and therapeutic potentials","volume":"195","author":"Tang","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1681\/ASN.2013101068","article-title":"Autophagy regulates TGF-\u03b2 expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction","volume":"25","author":"Ding","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem. Interact."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1242\/dev.01324","article-title":"TGF\u03b2 superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population","volume":"131","author":"Oxburgh","year":"2004","journal-title":"Development"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.14336\/AD.2021.1024","article-title":"Vascular Calcification in Chronic Kidney Disease: An Update and Perspective","volume":"13","author":"Ren","year":"2022","journal-title":"Aging Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1681\/ASN.2005060666","article-title":"Reducing the burden of cardiovascular calcification in patients with chronic kidney disease","volume":"16","author":"Qunibi","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000323434","article-title":"Vascular calcification in patients with chronic kidney disease: types, clinical impact and pathogenesis","volume":"20","year":"2011","journal-title":"Med. Princ. Pract."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: Pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/sdi.12411","article-title":"Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease","volume":"28","author":"Felsenfeld","year":"2015","journal-title":"Semin. Dial."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.kint.2017.11.036","article-title":"Prevention and treatment of hyperphosphatemia in chronic kidney disease","volume":"93","author":"Vervloet","year":"2018","journal-title":"Kidney Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ndt\/gfaa290","article-title":"The receptor activator of nuclear factor \u03ba\u0392 ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification","volume":"36","author":"Dusso","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1681\/ASN.2007121377","article-title":"A bench to bedside view of uremic toxins","volume":"19","author":"Vanholder","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/toxins6020416","article-title":"Binding affinity and capacity for the uremic toxin indoxyl sulfate","volume":"6","author":"Devine","year":"2014","journal-title":"Toxins"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Leong, S.C., and Sirich, T.L. (2016). Indoxyl Sulfate\u2014Review of Toxicity and Therapeutic Strategies. Toxins, 8.","DOI":"10.3390\/toxins8120358"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03190428","article-title":"Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate","volume":"27","author":"Banoglu","year":"2002","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/01.ASN.0000022017.96399.B2","article-title":"Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity","volume":"13","author":"Enomoto","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000350843","article-title":"Removal of protein-bound uraemic toxins by haemodialysis","volume":"35","author":"Niwa","year":"2013","journal-title":"Blood Purif."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000320359","article-title":"Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease","volume":"193","author":"Burns","year":"2011","journal-title":"Cells Tissues Organs"},{"key":"ref_59","first-page":"S15","article-title":"Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys","volume":"62","author":"Miyazaki","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1523-1755.2003.00906.x","article-title":"Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-\u03baB and free radical in proximal tubular cells","volume":"63","author":"Motojima","year":"2003","journal-title":"Kidney Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000324885","article-title":"Indoxyl sulfate downregulates renal expression of Klotho through production of ROS and activation of nuclear factor-\u0138B","volume":"33","author":"Shimizu","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ki.2011.445","article-title":"Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation","volume":"81","author":"Sun","year":"2012","journal-title":"Kidney Int."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gryp, T., Vanholder, R., Vaneechoutte, M., and Glorieux, G. (2017). p-Cresyl Sulfate. Toxins, 9.","DOI":"10.3390\/toxins9020052"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfj061","article-title":"Human sulfotransferases and their role in chemical metabolism","volume":"90","author":"Gamage","year":"2006","journal-title":"Toxicol. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.tiv.2015.07.020","article-title":"Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology","volume":"29","author":"Mutsaers","year":"2015","journal-title":"Toxicol. Vitr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and Pathologic Concentrations of Uremic Toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"F1005","DOI":"10.1152\/ajprenal.00535.2016","article-title":"Tumor necrosis factor-\u03b1, kidney function, and hypertension","volume":"313","author":"Mehaffey","year":"2017","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation","volume":"8","author":"Gabay","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"F217","DOI":"10.1152\/ajprenal.00611.2009","article-title":"Involvement of tumor necrosis factor-\u03b1 in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice","volume":"299","author":"Shahid","year":"2010","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00525.2012","article-title":"TNF-\u03b1 type 2 receptor mediates renal inflammatory response to chronic angiotensin II administration with high salt intake in mice","volume":"304","author":"Singh","year":"2013","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.7150\/thno.32352","article-title":"Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.nut.2015.05.006","article-title":"TMAO: A small molecule of great expectations","volume":"31","author":"Ufnal","year":"2015","journal-title":"Nutrition"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Romano, K.A., Vivas, E.I., Amador-Noguez, D., and Rey, F.E. (2015). Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio, 6.","DOI":"10.1128\/mBio.02481-14"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/nutrit\/nuab022","article-title":"Alzheimer\u2019s disease and gut microbiota: Does trimethylamine N-oxide (TMAO) play a role?","volume":"80","author":"Cardoza","year":"2022","journal-title":"Nutr. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/ndt\/gfk056","article-title":"Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis","volume":"21","author":"Bain","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/sdi.12694","article-title":"Hemodialysis-induced cardiovascular disease","volume":"31","author":"Ahmadmehrabi","year":"2018","journal-title":"Semin. Dial."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.2014111063","article-title":"Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden","volume":"27","author":"Stubbs","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ki.5001632","article-title":"ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease","volume":"70","author":"Caglar","year":"2006","journal-title":"Kidney Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.V891437","article-title":"Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients","volume":"8","author":"Anderstam","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"16005","DOI":"10.1038\/s41598-020-72943-2","article-title":"Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4\/ROS\/ERK signaling pathway","volume":"10","author":"Jayachandran","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","article-title":"Hypertension in CKD: Core Curriculum 2019","volume":"74","author":"Ku","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/5584_2016_84","article-title":"Hypertension in Chronic Kidney Disease","volume":"956","author":"Hamrahian","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","article-title":"Essential hypertension","volume":"370","author":"Messerli","year":"2007","journal-title":"Lancet"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1211199","DOI":"10.3389\/fcvm.2023.1211199","article-title":"When blood pressure refuses to budge: Exploring the complexity of resistant hypertension","volume":"10","author":"Champaneria","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Flack, J.M., Buhnerkempe, M.G., and Moore, K.T. (2024). Resistant Hypertension: Disease Burden and Emerging Treatment Options. Curr. Hypertens. Rep., 1\u201317.","DOI":"10.1007\/s11906-023-01282-0"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11906-020-01081-x","article-title":"Resistant Hypertension in Chronic Kidney Disease (CKD): Prevalence, Treatment Particularities, and Research Agenda","volume":"22","author":"Georgianos","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Weldegiorgis, M., and Woodward, M. (2020). The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: A systematic review and meta-analysis. BMC Nephrol., 21.","DOI":"10.1186\/s12882-020-02151-7"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1093\/ndt\/gfad118","article-title":"Hypertension in chronic kidney disease\u2014Treatment standard 2023","volume":"38","author":"Georgianos","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure","volume":"327","author":"Converse","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"R633","DOI":"10.1152\/ajpregu.00258.2005","article-title":"Physiology in perspective: The Wisdom of the Body. Neural control of the kidney","volume":"289","author":"DiBona","year":"2005","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1476-5381.1985.tb16154.x","article-title":"The role of \u03b1-adrenoceptors in the regulation of renal tubular sodium reabsorption and renin secretion in the rabbit","volume":"84","author":"Hesse","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.114.03335","article-title":"Sympathetic stimulation of thiazide-sensitive sodium chloride cotransport in the generation of salt-sensitive hypertension","volume":"64","author":"Terker","year":"2014","journal-title":"Hypertension"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1159\/000368527","article-title":"The Thiazide-Sensitive Co-Transporter Promotes the Development of Sodium Retention in Mice with Diet-Induced Obesity","volume":"40","author":"Davies","year":"2015","journal-title":"Kidney Blood Press. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.111.185074","article-title":"Systemic and renal-specific sympathoinhibition in obesity hypertension","volume":"59","author":"Lohmeier","year":"2012","journal-title":"Hypertension"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11906-020-01067-9","article-title":"ENaC in Salt-Sensitive Hypertension: Kidney and Beyond","volume":"22","author":"Pitzer","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1172\/JCI43124","article-title":"Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor\u2013dependent pathway","volume":"121","author":"Shibata","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.122.320818","article-title":"DC ENaC-Dependent Inflammasome Activation Contributes to Salt-Sensitive Hypertension","volume":"131","author":"Pitzer","year":"2022","journal-title":"Circ. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Schraven","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"El Meouchy, P., Wahoud, M., Allam, S., Chedid, R., Karam, W., and Karam, S. (2022). Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012305"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.HYP.0000113294.06704.64","article-title":"Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.2005121256","article-title":"The endothelin system and its antagonism in chronic kidney disease","volume":"17","author":"Dhaun","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e14602","DOI":"10.14814\/phy2.14602","article-title":"Nocturnal blood pressure is associated with sympathetic nerve activity in patients with chronic kidney disease","volume":"8","author":"Jeong","year":"2020","journal-title":"Physiol. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1249\/JES.0000000000000065","article-title":"The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise","volume":"44","author":"Martens","year":"2016","journal-title":"Exerc. Sport Sci. Rev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2215\/CJN.14420920","article-title":"Nocturnal Systolic Hypertension and Adverse Prognosis in Patients with CKD","volume":"16","author":"Wang","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/01.CIR.96.6.1859","article-title":"Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension","volume":"96","author":"Uzu","year":"1997","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ajh.2012.82","article-title":"Assessment of the diurnal blood pressure profile and detection of non-dippers based on home or ambulatory monitoring","volume":"25","author":"Stergiou","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/HYPERTENSIONAHA.121.17440","article-title":"Nocturnal Hypertension and Heart Failure: Mechanisms, Evidence, and New Treatments","volume":"78","author":"Kario","year":"2021","journal-title":"Hypertension"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Rysz, J., Gluba-Brz\u00f3zka, A., Franczyk, B., Jab\u0142onowski, Z., and Cia\u0142kowska-Rysz, A. (2017). Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081702"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.biochi.2019.05.002","article-title":"Cystatins in cancer progression: More than just cathepsin inhibitors","volume":"166","author":"Breznik","year":"2019","journal-title":"Biochimie"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj2680287","article-title":"Structure and expression of the human cystatin C gene","volume":"268","author":"Abrahamson","year":"1990","journal-title":"Biochem. J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/bss0700179","article-title":"Cystatins","volume":"70","author":"Abrahamson","year":"2003","journal-title":"Biochem. Soc. Symp."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cca.2014.08.039","article-title":"Biomarkers of renal function, which and when?","volume":"438","author":"Wasung","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR\u2014History, indications, and future research","volume":"38","author":"Filler","year":"2005","journal-title":"Clin. Biochem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1515\/CCLM.2001.141","article-title":"Determination of serum cystatin C: biological variation and reference values","volume":"39","author":"Galteau","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1373\/clinchem.2012.184259","article-title":"The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: Evolution not revolution","volume":"59","author":"Lamb","year":"2013","journal-title":"Clin. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1523-1755.2000.00214.x","article-title":"Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy","volume":"58","author":"Banba","year":"2000","journal-title":"Kidney Int."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.ki.5000014","article-title":"Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice","volume":"69","author":"Chow","year":"2006","journal-title":"Kidney Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1523-1755.2004.00367.x","article-title":"Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury","volume":"65","author":"Chow","year":"2004","journal-title":"Kidney Int."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2005-1718","article-title":"Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy","volume":"91","author":"Takebayashi","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_124","first-page":"1741","article-title":"Expression of connective tissue growth factor (CTGF\/CCN2) in breast cancer cells is associated with increased migration and angiogenesis","volume":"38","author":"Chien","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.510300425","article-title":"Expression of connective tissue growth factor in experimental rat and human liver fibrosis","volume":"30","author":"Paradis","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2337\/diacare.29.01.06.dc05-1670","article-title":"Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy","volume":"29","author":"Nguyen","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_128","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Galitzer","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.1991.63","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"39","author":"Kuncio","year":"1991","journal-title":"Kidney Int."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cca.2022.08.018","article-title":"Predictive markers in chronic kidney disease","volume":"535","author":"Priyadarshini","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"F885","DOI":"10.1152\/ajprenal.00331.2013","article-title":"Kidney injury molecule-1 expression in IgA nephropathy and its correlation with hypoxia and tubulointerstitial inflammation","volume":"306","author":"Lin","year":"2014","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.2015.314","article-title":"Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes","volume":"89","author":"Nowak","year":"2016","journal-title":"Kidney Int."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1159\/000492407","article-title":"Prognostic Value of Urinary Calprotectin, NGAL and KIM-1 in Chronic Kidney Disease","volume":"43","author":"Seibert","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"ref_137","first-page":"32","article-title":"Comparison of BTP, NGAL, KIM-1, & ADMA biomarkers in CKD and non-CKD subjects","volume":"14","author":"Bansal","year":"2023","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"20420188221083518","DOI":"10.1177\/20420188221083518","article-title":"Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetes","volume":"13","author":"Buyadaa","year":"2022","journal-title":"Ther. Adv. Endocrinol. Metab."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/9\/751\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:33:38Z","timestamp":1760106818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/9\/751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":138,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["cells13090751"],"URL":"https:\/\/doi.org\/10.3390\/cells13090751","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}